<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">81415</article-id><article-id pub-id-type="doi">10.7554/eLife.81415</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Structural Biology and Molecular Biophysics</subject></subj-group></article-categories><title-group><article-title>Computational model of the full-length TSH receptor</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-284387"><name><surname>Mezei</surname><given-names>Mihaly</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0294-4307</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-266386"><name><surname>Latif</surname><given-names>Rauf</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4226-3728</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-278232"><name><surname>Davies</surname><given-names>Terry F</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><institution content-type="dept">Department of Pharmacological Sciences</institution>, <institution>Icahn School of Medicine at Mount Sinai</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Department of Medicine</institution>, <institution>Icahn School of Medicine at Mount Sinai</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-222480"><name><surname>Gupta</surname><given-names>Yogesh K</given-names></name><role>Reviewing editor</role><aff><institution>The University of Texas Health Science Center at San Antonio</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>Mihaly.Mezei@mssm.edu</email> (MM);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>28</day><month>10</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e81415</elocation-id><history><date date-type="received"><day>26</day><month>06</month><year>2022</year></date><date date-type="accepted"><day>12</day><month>10</month><year>2022</year></date></history><permissions><copyright-statement>Â© 2022, Mezei et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Mezei et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-81415-v1.pdf"/><abstract><p>The receptor for thyroid stimulating hormone (TSHR), a GPCR, is of particular interest as the primary antigen in autoimmune hyperthyroidism (Graves' disease) caused by stimulating TSHR antibodies.  To date, only one domain of the extracellular region of the TSHR has been crystallized.  We have run a 1000ns Molecular Dynamic simulation on a model of the entire TSHR generated by merging the extracellular region of the receptor, obtained using artificial intelligence, with our recent homology model of the transmembrane domain, embedded it in a lipid membrane solvated it with water and counterions. The simulations showed that the structure of the transmembrane and leucine-rich domains were remarkably constant while the linking region (LR), known more commonly as the 'hinge region', showed significant flexibility, forming several transient secondary structural elements. Furthermore, the relative orientation of the leucine-rich domain with the rest of the receptor was also seen to be variable. These data suggest that this linker region is an intrinsically disordered protein (IDP). Furthermore, preliminary data simulating the full TSHR model complexed with its ligand (TSH) showed that (a) there is a strong affinity between the linker region and TSH ligand and (b) the association of the linker region and the TSH ligand reduces the structural fluctuations in the linker region. This full-length model illustrates the importance of the linker region in responding to ligand binding and lays the foundation for studies of pathologic TSHR autoantibodies complexed with the TSHR to give further insight into their interaction with the flexible linker region.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000052</institution-id><institution>NIH Office of the Director</institution></institution-wrap></funding-source><award-id>DK069713</award-id><principal-award-recipient><name><surname>Mezei</surname><given-names>Mihaly</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution>Veterans Administration merit award</institution></institution-wrap></funding-source><award-id>BX000800</award-id><principal-award-recipient><name><surname>Davies</surname><given-names>Terry F</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100016141</institution-id><institution>Segal Family Foundation</institution></institution-wrap></funding-source><award-id>00000000</award-id><principal-award-recipient><name><surname>Davies</surname><given-names>Terry F</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Terry F Davies, is member of the Board of Kronus Inc (Starr, ID, USA); MM, and RF have nothing to disclose..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>The initial model generated is available from the Dryad server; URL: https://doi.org/10.5061/dryad.rjdfn2zdp.The software used for the analysis are available at the URL https://mezeim01.u.hpc.mssm.edu</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Mezei </collab><collab>et al</collab></person-group><year iso-8601-date="2022">2022</year><source>Data from: Computational model of the full-length TSH receptor</source><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.5061/dryad.rjdfn2zdp">http://dx.doi.org/10.5061/dryad.rjdfn2zdp</ext-link><comment>Dryad Digital Repository, doi:10.5061/dryad.rjdfn2zdp</comment></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation id="dataset2" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Jumper RE</collab><collab>et al</collab></person-group><year iso-8601-date="2021">2021</year><source>Swissprot/Uniprot</source><ext-link ext-link-type="uri" xlink:href="https://web.expasy.org">https://web.expasy.org</ext-link><comment>/P1/64/73</comment></element-citation><element-citation id="dataset3" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Mezei M</collab><collab>Latif R</collab><collab>Das B</collab><collab>Davies TF</collab></person-group><year iso-8601-date="2021">2021</year><source>An improved computational model of the transmembrane domain of the thyroid stimulating hormone receptor</source><ext-link ext-link-type="uri" xlink:href="https://mezeim01.u.hps.mssm.edu/prod/TMD3">https://mezeim01.u.hps.mssm.edu/prod/TMD3</ext-link><comment>TMD3</comment></element-citation></p></sec></sec></back></article>